Current Vascular Pharmacology
Title:Meet Our Editorial Board Member
Volume: 16 Issue: 2
Author(s): Dimitrios N. Tziakas
Affiliation:
Export Options
About this article
Cite this article as:
Tziakas N. Dimitrios , Meet Our Editorial Board Member, Current Vascular Pharmacology 2018; 16 (2) . https://dx.doi.org/10.2174/157016111602180126100954
DOI https://dx.doi.org/10.2174/157016111602180126100954 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy
Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Brain Targeting of siRNA via Intranasal Pathway
Current Pharmaceutical Design Value of MRI T2 FLAIR Vascular Hyperintensities Combined with DWI ASPECTS in Predicting the Prognosis of Acute Cerebral Infarction with Endovascular Treatment
Current Medical Imaging Hyperhomocysteinemia, Pteridines and Oxidative Stress
Current Drug Metabolism Serpinins: Role in Granule Biogenesis, Inhibition of Cell Death and Cardiac Function
Current Medicinal Chemistry Meet Our Regional Editor
Cardiovascular & Hematological Agents in Medicinal Chemistry Hydrophobically Modified <i>Abelmoschus esculentus</i> Polysaccharide Based Nanoparticles and Applications: A Review
Current Drug Discovery Technologies Changes of Expression of the Protein C Pathway Components in LPSInduced Endotoxemia–Implication for Sepsis
Cardiovascular & Hematological Disorders-Drug Targets Neuroprotective Potential of <i>Bacopa monnieri</i>: Modulation of Inflammatory Signals
CNS & Neurological Disorders - Drug Targets Ziconotide: Neuronal Calcium Channel Blocker for Treating Severe Chronic Pain
Current Medicinal Chemistry Editorial (Hot Topics: Inflammation: A Key Mechanism of Adverse Reactions to Coronary Stent and A Target for Future Therapies)
Current Vascular Pharmacology Diabetic Nephropathy: Focus on Current and Future Therapeutic Strategies
Current Drug Metabolism Biomarkers of Senescence during Aging as Possible Warnings to Use Preventive Measures
Current Medicinal Chemistry Cardiovascular Risk Factors and Dietary Patterns
Current Nutrition & Food Science Expression and Role of the Calcium-Sensing Receptor in the Blood Vessel Wall
Current Pharmaceutical Biotechnology Critical Parameters for Genome Editing Using Zinc Finger Nucleases
Mini-Reviews in Medicinal Chemistry Acknowledgements to Reviewers
Current Cardiology Reviews Preclinical Safety and Pharmacokinetic Profile of 3K3A-APC, a Novel, Modified Activated Protein C for Ischemic Stroke
Current Pharmaceutical Design Heat Stress Nephropathy: What Have We Learned?
Endocrine, Metabolic & Immune Disorders - Drug Targets Understanding Stem Cell-Mediated Brain Repair Through Neuroimaging
Current Stem Cell Research & Therapy Fibrinolysis in COVID-19: Impact on Clot Lysis and Modulation of Inflammation
Current Drug Targets